Radialogica LLC

Radialogica is a healthtech company specializing in radiation oncology quality management software and services. The company provides tools and services to evaluate, manage, and enhance the quality and safety of radiotherapy treatment planning and delivery for cancer patients. Radialogica operates in two primary business segments: Clinical Trials Services and Clinical Software Tools. In clinical trials, Radialogica partners with pharmaceutical sponsors, biotechnology companies, CROs, and medical device manufacturers to design and implement comprehensive radiotherapy quality assurance programs. Services include development of RT treatment guidelines, collection and aggregation of DICOM-RT treatment plan data, extraction and evaluation of dosimetric parameters, and prospective or retrospective case reviews. The company has processed over 10,000 radiotherapy case submissions across clinical and research projects, operating across 6 continents, 50+ countries, and 600+ clinical sites. Clinical software offerings include SciMoCa™, a Monte Carlo dose calculation and beam model verification platform for dose verification and plan quality evaluation, and fullAccess™, an integrated radiotherapy data display, communication, and analysis platform enabling multi-disciplinary access and sharing of RT data across the continuum of care. These tools have been deployed at over 225 clinical sites worldwide and have impacted quality of care for over 1.5 million patient treatments. Radialogica addresses the significant variability in treatment planning and delivery inherent in radiation oncology through software-enabled prospective quality review and data analytics. The company serves pharma trials, medical registries, payer benefits management, and provider quality benchmarking programs. All services leverage proprietary software tools and technology infrastructure purpose-built for RT data acquisition, processing, and analysis.